
    
      Prospective, three-stage, single arm, multi-site, clinical investigation evaluating the
      safety and efficacy of the reSept ASD Occluder in treating clinically significant secundum
      ASD. Outcomes/endpoints of the clinical investigation will be compared with established
      performance goals for FDA approved transcatheter secundum ASD occluders.
    
  